Pathway analysis using KEGG indicated significant enrichment in downregulated proteins associated with MAPK signaling, EGFR tyrosine kinase inhibitor resistance, and PI3K-Akt signaling—key oncogenic pathways commonly implicated in melanoma progression (Figure 6D). The gene discussed is AKT1; the disease is melanoma.